Loading...
CardieX Limited
CDX.AX•ASX
Healthcare
Medical - Devices
A$0.03
A$-0.00(-8.82%)
CardieX Limited (CDX.AX) Financial Performance & Income Statement Overview
Review CardieX Limited (CDX.AX) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
136.86%
↑ 136.86%
Operating Income Growth
69.82%
↑ 69.82%
Net Income Growth
64.51%
↑ 64.51%
Operating Cash Flow Growth
35.63%
↑ 35.63%
Operating Margin
-215.03%
↓ 215.03%
Gross Margin
85.37%
↑ 85.37%
Net Profit Margin
-254.16%
↓ 254.16%
ROE
-272.20%
↓ 272.20%
ROIC
-175.75%
↓ 175.75%
CardieX Limited (CDX.AX) Income Statement & Financial Overview
Analyze CardieX Limited’s CDX.AX earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $1.65M | $1.65M | $1.22M | $1.22M |
| Cost of Revenue | $191900.00 | $191900.00 | $226829.00 | $226829.00 |
| Gross Profit | $1.45M | $1.45M | $989331.00 | $989331.00 |
| Gross Profit Ratio | $0.88 | $0.88 | $0.81 | $0.81 |
| R&D Expenses | $668175.00 | $668175.00 | $588513.00 | $588513.00 |
| SG&A Expenses | $3.74M | $3.74M | $3.60M | $3.60M |
| Operating Expenses | $4.41M | $4.41M | $4.18M | $4.18M |
| Total Costs & Expenses | $4.60M | $4.60M | $4.41M | $4.41M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $575193.00 | $0.00 |
| Depreciation & Amortization | $18280.00 | $18280.00 | $18280.00 | $18194.00 |
| EBITDA | -$2.94M | -$2.94M | -$3.18M | -$3.18M |
| EBITDA Ratio | -$1.79 | -$1.79 | -$2.61 | -$2.61 |
| Operating Income | -$2.96M | -$2.96M | -$3.20M | -$3.20M |
| Operating Income Ratio | -$1.80 | -$1.80 | -$2.63 | -$2.63 |
| Other Income/Expenses (Net) | -$528588.00 | -$528588.00 | -$591145.00 | -$591145.00 |
| Income Before Tax | -$3.49M | -$3.49M | -$3.79M | -$3.79M |
| Income Before Tax Ratio | -$2.12 | -$2.12 | -$3.11 | -$3.11 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$3.49M | -$3.49M | -$3.79M | -$3.79M |
| Net Income Ratio | -$2.12 | -$2.12 | -$3.11 | -$3.11 |
| EPS | -$0.01 | -$0.01 | -$0.01 | -$0.01 |
| Diluted EPS | -$0.01 | -$0.01 | -$0.01 | -$0.01 |
| Weighted Avg Shares Outstanding | $296.22M | $290.57M | $253.84M | $253.84M |
| Weighted Avg Shares Outstanding (Diluted) | $296.22M | $296.22M | $257.46M | $257.46M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan